Extended‐release naltrexone (XR‐NTX) for opioid use disorder in clinical practice: Vivitrol's Cost and Treatment Outcomes Registry
Published since 1884 by the Society for the Study of Addiction
Editor-in-Chief, John Marsden
Published since 1884 by the Society for the Study of Addiction
Editor-in-Chief, John Marsden